Science News and Activities
Presence
Science Corporation develops neurotechnology and biomedical devices. Its products and services include brain interfaces, vision restoration systems, and research tools for patients, clinics, and medical researchers.
Science products and services overview:
- Brain interfaces
- Vision restoration
- Biomedical devices
- Research tools
Revenue: ~$10 million
Employees: 150
Headquarters: Alameda, United States (USA)
Science is one of the...
Acquisition, funding and merger involving Science.
- Science has just announced a $230 Million fundraising (posted on May 18 2026).
- Science has just announced a $230 Million fundraising (posted on March 6 2026).
Executives
View the org chart displaying its 18 main executives
Most searched biographies at Science
- Max Hodak, Chief Executive Officer
- Ralf Hornig, Director of Clinical Affairs
- Davin Hsieh, Vice President of Finance
Popular executive movements at Science
- Dianna Ty has joined the company as Supply Chain Finance Manager (posted on July 3 2026).
- Murat Guenes has joined the company as Medical Director, Brain Computer Interfaces (posted on April 1 2026).
- Darius Shahida will join the company as Chief Strategy Officer on Jan. 5, 2026 (posted on December 14 2025).
Create your alert
to follow the executive moves at Science.
Biotechnology
Science has 2,424 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Vertex Pharmaceuticals (United States (USA)).
Popular M&A news in Biotechnology
- Ipsen has announced the acquisition of Kartos Therapeutics (posted on July 3 2026).
- BridgeBio has just announced a $1,000 Million fundraising (posted on July 2 2026).
- Flare Therapeutics has just announced a $85 Million fundraising (posted on July 2 2026).
Popular contacts in Biotechnology
News
Press releases by Science
- Science's Axon Terminal Wins 2026 iF Design Award | Science Corporation
- NYX and LUX: Introducing Science's Chip Families for Neural Recording And Stimulation | Science Corporation
- Science Appoints Murat Günel, MD, as Medical Director for Brain-Computer Interfaces | Science Corporation
- Expert Opinion: José-Alain Sahel, M.D., on Science’s PRIMA Implant and the ‘Undreamt of’ Progress in Restoring Vision to Clinical Trial Patients | Science Corporation
- Science Closes $230 Million Series C to Fund Commercialization of PRIMA BCI Retinal Implant and Expansion of Clinical Trials | Science Corporation
- Science Corp. and Neurosoft Bioelectronics Announce BCI Ecosystem Partnership: Science’s World-Class BCI Systems To Support Neurosoft's Pioneering Neural Data Platform | Science Corporation
- Science Founder and CEO Max Hodak Named to Time 100 Health List of the World’s Most Influential Leaders in Health | Science Corporation
- Expert Opinion: Frank Holz, M.D. on Science’s PRIMA Implant and the New Reality of Restoring Vision to Clinical Trial Patients Who Had Been Functionally Blind | Science Corporation
- In Editorial, The New England Journal of Medicine Calls Science Corporation's PRIMA Implant 'The First Treatment to Restore Vision' In Patients Suffering From Advanced Geographic Atrophy Due to Age-related Macular Degeneration | Science Corporation
- Science Vessel: Taking Perfusion from a Bridge to a Destination | Science Corporation
- View more press releases Close
Social media about Science
- Science on Wikipedia, Google News & Yahoo Finance
- Science on LinkedIn, X (Twitter) & YouTube
